The BioCentury Show

About The BioCentury Show

Tune in to BioCentury’s in-depth conversations with global leaders who are advancing the future of medicine. Join our Senior Editors in face-to-face discussions with scientific KOLs, top executives, VCs, and key policymakers, dissecting the most urgent public health issues. The BioCentury Show is THE only place where BioCentury’s experts join top innovators and global influencers to show how science is being turned into medicine. Don't miss this event, every two weeks, now available as a video webcast or audio podcast (https://www.biocentury.com/the-biocentury-show/watch-or-listen).

Publisher

BioCentury

Category

business · science · science

Language

en

Explicit

No

First episode

17 Apr 2024

Latest episode

30 Oct 2026

Latest episodes

78 episodes in the feed.

1. 

   30 Oct 2026

   Ep. 123 - Gilde’s Joep Muijrers on why patients belong in the investment process

   On this edition of The BioCentury Show, Gilde's Joep Muijrers joins BioCentury’s Stephen Hansen to discuss how the firm’s Impact Council of former regulators, payers, HTA leaders, and patient advocates shapes its investment decisions. Muijrers explains how council input steered Gilde away from one deal and toward another, diagnostics company Karius, and why he argues patient perspectives belong alongside physician input in diligence and development strategy. He also describes the frameworks G...

2. 

   21 Oct 2026

   Ep. 122 - Tigermed's Britney Winterberger's take on running trials in the U.S. and China

   Tigermed, the largest clinical CRO in China, has expanded into more than 50 countries and is growing its North American operations, offering full-service support from preclinical through Phase IV. On this sponsored edition of The BioCentury Show, Britney Winterberger, Tigermed’s VP and head of North America clinical operations, tells BioCentury Executive Editor Jeff Cranmer how the CRO helps U.S. sponsors run trials in China and Chinese sponsors run trials in the U.S. — and why combining both...

3. 

   17 Oct 2026

   Ep. 121 - Arrowhead’s Chris Anzalone on the future of RNAi

   Arrowhead Pharmaceuticals can now deliver siRNA to seven cell types, and new data showing subcutaneous delivery to the brain could push RNAi therapies well beyond the liver. On this edition of The BioCentury Show, Arrowhead Chairman, President, and CEO Chris Anzalone joins BioCentury’s Stephen Hansen to discuss where siRNA has the edge over ASOs, what the Phase III miss for Novartis’ pelacarsen means for olpasiran, the Lp(a) therapy Arrowhead partnered with Amgen, and the growth outlook for p...

Who has been a guest on The BioCentury Show

Names identified in recent episode analyses. Showing up to five guests.

• Karen Knudsen
• Chris Hollowood
• Sander Slootweg
• Daniel Mahony
• Najat Khan

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

YouTube views

37,894

Score snapshot 15 Sept 2025

Apple Podcasts (US)

4.6 / 5

11 ratings

Spotify

5.0 / 5

10 ratings

Podcast Authority Score: 60 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

55

Social presence

0

YouTube

85

Engagement

77

Contact The BioCentury Show

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Shows with a similar audience

• 

  BioCentury This Week

• 

  Biotech Hangout

• 

  The Readout Loud

• 

  The Long Run with Luke Timmerman

• 

  Biotech 2050 Podcast

• 

  Business Of Biotech

Questions about The BioCentury Show